Evidence map›Paper›PMID 42661063›Full record

ArticleEMBO reports2026

Sulf1 regulates inflammation via modulation of TGF-β dependent epicardial activation.

Gursimran Kaur Bajwa, Gülsüm Kayman Kürekçi, Rubén Marín-Juez

Abstract read
PubMed Publisher
In one paragraph

Article in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gursimran Kaur BajwaCentre de Recherche Azrieli, Centre Hospitalier Universitaire Sainte-Justine, Montréal, QC, Canada.
Gülsüm Kayman KürekçiCentre de Recherche Azrieli, Centre Hospitalier Universitaire Sainte-Justine, Montréal, QC, Canada.
Rubén Marín-JuezCentre de Recherche Azrieli, Centre Hospitalier Universitaire Sainte-Justine, Montréal, QC, Canada. ruben.marin.juez.hsj@ssss.gouv.qc.ca.ORCID http://orcid.org/0000-0001-5903-7463

Funding

Canadian Institutes of Health Research (CIHR) PJT-178037
6 · The paper itself

Abstract

Unlike adult humans, zebrafish can regenerate their hearts after injury. After cardiac injury, the epicardium is rapidly activated to contribute both signaling factors and progenitor cells that are essential to establish a pro-regenerative niche. Concurrent with epicardial activation, cardiac injury triggers a robust inflammatory cascade. While the epicardial response is crucial for cardiac regeneration, the mechanisms by which it modulates the immune landscape remain largely unknown. Sulfatases have emerged as important modulators of inflammation through regulating cytokine and growth factor signaling. Here we find that the zebrafish epicardium upregulates the endo-sulfatase Sulf1 after injury. Using newly generated gain- and loss-of-function tools, we show that Sulf1 regulates epicardial activation and regeneration via TGF-β signaling. Abrogation of sulf1 results in cardiomyocyte regeneration defects and increased fibrosis. Moreover, disrupted TGF-β signaling in sulf1 mutants stimulates inflammation and macrophage recruitment. scRNA-seq analyses reveal that epicardial Sulf1 regulates the recruitment of pro-inflammatory macrophage subsets. Epicardial overexpression of sulf1 reverses TGF-β signaling and inflammation phenotypes. These data show that Sulf1 modulates TGF-β-dependent epicardial activation to regulate cardiac inflammation during heart regeneration.

Indexed as

InflammationPericardiumSulfatasesSulfotransferasesTransforming Growth Factor betaZebrafish ProteinsAnimalsFibrosisMacrophagesMyocytes, CardiacRegenerationSignal TransductionZebrafishSulfatasesSulfotransferasesTransforming Growth Factor betaZebrafish Proteins

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.